CGL · Class II · 21 CFR 862.1225

FDA Product Code CGL: Electrode, Ion Based, Enzymatic, Creatinine

Leading manufacturers include Nova Biomedical Corp..

8
Total
8
Cleared
168d
Avg days
1991
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period
Review times improving: avg 88d recently vs 180d historically

FDA 510(k) Cleared Electrode, Ion Based, Enzymatic, Creatinine Devices (Product Code CGL)

8 devices
1–8 of 8

About Product Code CGL - Regulatory Context

510(k) Submission Activity

8 total 510(k) submissions under product code CGL since 1991, with 8 receiving FDA clearance (average review time: 168 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA 510(k) Review Time - CGL Product Code

Recent submissions under CGL have taken an average of 88 days to reach a decision - down from 180 days historically, suggesting improved FDA processing for this classification.

CGL devices are reviewed by the Chemistry panel. Browse all Chemistry devices →